Results 91 to 100 of about 54,052 (308)

A Case of Multiple Mitochondrial Dysfunctions Syndrome 1 and Review of the Literature

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Multiple mitochondrial dysfunctions syndrome 1 (MMDS1, MIM #605711) due to NFU1 gene defects is an ultra‐rare autosomal recessive inborn error of metabolism associated with reduced function of NFU1 iron–sulfur cluster (ISC) scaffold protein.
Charles R. DiFalco   +6 more
wiley   +1 more source

Ranking the factors influencing polycyclic aromatic hydrocarbons (PAHs) build-up on urban roads [PDF]

open access: yes, 2017
An in-depth understanding of polycyclic aromatic hydrocarbons (PAHs) build-up on urban roads is essential for effective stormwater treatment design. Past research studies have pointed out the relationship between influential factors and PAHs build-up ...
Ma, Yukun   +9 more
core   +1 more source

Optimisation of ASE for Determination of Organic Compounds Bound to Particulate Matter [PDF]

open access: yesKemija u Industriji
Polycyclic aromatic hydrocarbons (PAHs), due to their harmful carcinogenic and mutagenic effects on human health, are significant organic pollutants in the air.
Tajana Horvat   +3 more
doaj   +1 more source

A Comparison of Polycyclic Aromatic Hydrocarbon Mobilization from Environmental Matrices [PDF]

open access: yes
A method has been developed to analyse PAHs in solid environmental matrices using an in-situ PFE-GC-MS method. The method involves the use of 2 g of alumina as the in-situ clean-up sorbent, in order to remove interferences and impurities in the soils ...
Lorenzi, Damien
core  

Risk stratification in PAH

open access: yesGlobal Cardiology Science and Practice, 2020
[No abstract. Showing first paragraph of article]Pulmonary arterial hypertension (PAH) is a chronic disease of the pulmonary vasculature characterized by progressive narrowing of the pulmonary arteries leading to increased pulmonary vascular resistance, right heart failure, and ultimately premature death.There has been a significant improvement in the ...
openaire   +3 more sources

Cycloazulenylene

open access: yesAngewandte Chemie International Edition, EarlyView.
A strained macrocycle consisting solely of azulene subunits, named [6]cycloparaazulenylene ([6]CPA), is presented. The macrocycle exhibits a notably narrow HOMO–LUMO gap for a pristine azulene species, strain‐induced red‐shifted absorption, and an unusual tubular packing motif elucidated via single‐crystal XRD.
Clara Douglas   +8 more
wiley   +1 more source

AQUA-GAPS/MONET-Derived Concentrations and Trends of PAHs and Polycyclic Musks across Global Waters [PDF]

open access: yes
Polycyclic aromatic hydrocarbons (PAHs), released from petrogenic, pyrogenic or diagenetic sources (degradation of wood materials), are of global concern due to their adverse effects, and potential for long-range transport. While dissolved PAHs have been
Zeng, Eddy Y.   +47 more
core   +1 more source

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

open access: yesArthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro   +17 more
wiley   +1 more source

Occurrence and ecological risk of PAHs in urban road runoff in Beijing

open access: yesWater Science and Technology
The occurrence and ecological risks of 16 polycyclic aromatic hydrocarbons (PAHs) in different types of urban road runoff in Beijing during two typical rainfall events were studied.
Xiaoran Zhang   +8 more
doaj   +1 more source

Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mosliciguat (BAY 1237592), the first soluble guanylate cyclase (sGC) activator in a dry powder inhaler (DPI), could potentially treat pulmonary hypertension with a more targeted delivery than systemic sGC stimulators. We report safety and tolerability of mosliciguat in healthy men.
Johannes Nagelschmitz   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy